BG

Bob Goeltz

Chief Financial Officer

Arcus Biosciences

Therapeutic Areas

Arcus Biosciences Pipeline

DrugIndicationPhase
CasdatifanLate-line Kidney CancerPhase 3
Inflammation ProgramsNot SpecifiedNot Specified